nstemi -> nstemi | Ramipril on par with sacubitrilvalsartan combo in

Merek: nstemi

nstemi->NSTEMI). NSTEMI patients showed a marginally higher risk for the primary outcome than STEMI patients after adjusting for potential

nstemi->nstemi | Ramipril on par with sacubitrilvalsartan combo in

Rp.9487
Rp.76339-90%
Kuantitas
Dari Toko yang Sama